Acumen PharmaceuticalsABOS
那斯達克 · USD
1.96
+0.06
(+3.16%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Acumen PharmaceuticalsABOS
1.96
+0.06
(+3.16%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 26,513 | 41,750 | 30,370 | - | - | 24,381 | - | - | 16,039 | 13,478 |
研發費用 | 21,968 | 37,125 | 25,266 | 34,569 | 27,247 | 19,533 | 12,449 | 13,293 | 11,179 | 9,133 |
推銷及管理費用 | 4,545 | 4,625 | 5,104 | 5,028 | 5,018 | 4,848 | 5,325 | 5,193 | 4,860 | 4,345 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -26,513 | -41,750 | -30,370 | -39,597 | -32,265 | -24,381 | -17,774 | -18,486 | -16,039 | -13,478 |
其他收入及費用 | 1,130 | 1,846 | 2,597 | 3,480 | 3,527 | 4,848 | 3,901 | 2,570 | 3,082 | 1,868 |
利息費用 | 1,068 | 1,046 | 1,023 | 1,037 | 1,027 | 1,004 | 1,000 | 581 | - | - |
稅前純益 | -26,451 | -40,950 | -28,796 | -37,154 | -29,765 | -20,537 | -14,873 | -16,497 | -12,957 | -11,610 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -26,451 | -40,950 | -28,796 | -37,154 | -29,765 | -20,537 | -14,873 | -16,497 | -12,957 | -11,610 |
基本每股稅後盈餘(元) | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 | -0.34 | -0.25 | - | -0.24 | -0.28 |
稀釋每股稅後盈餘(元) | -0.44 | -0.67 | -0.48 | -0.62 | -0.50 | -0.34 | -0.25 | -0.29 | -0.23 | -0.28 |
基本平均股數(千股) | 60573.00 | 60573.00 | 60525.00 | 60083.00 | 60079.00 | 60079.00 | 59812.00 | - | 54229.00 | 41025.00 |
稀釋平均股數(千股) | 60573.00 | 60573.00 | 60525.00 | 60083.00 | 60079.00 | 60079.00 | 59812.00 | - | 54229.00 | 41025.00 |
還原基本每股稅後盈餘(元) | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 | -0.34 | -0.25 | - | -0.24 | -0.28 |
還原稀釋每股稅後盈餘(元) | -0.44 | -0.67 | -0.48 | -0.62 | -0.50 | -0.34 | -0.25 | -0.29 | -0.23 | -0.28 |
還原基本平均股數(千股) | 60,573 | 60,573 | 60,525 | 60,083 | 60,079 | 60,079 | 59,812 | - | 54,229 | 41,025 |
還原稀釋平均股數(千股) | 60,573 | 60,573 | 60,525 | 60,083 | 60,079 | 60,079 | 59,812 | - | 54,229 | 41,025 |
EBITDA(千元) | -25,611 | -39,913 | -28,316 | -36,489 | -30,070 | -20,947 | -15,592 | -17,654 | -13,627 | -11,857 |